| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | sotrastaurin | CTRPv2 | pan-cancer | AAC | 0.15 | 7e-05 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0001 |
| mRNA | avrainvillamide | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | AZD6482 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | GDC-0941 | gCSI | pan-cancer | AAC | -0.18 | 0.002 |
| mRNA | Repligen 136 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.004 |
| mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | -0.1 | 0.005 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | -0.16 | 0.005 |
| mRNA | navitoclax:pluripotin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.096 | 0.006 |
| mRNA | JW-74 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.007 |